Agios Pharmaceuticals Inc
NASDAQ:AGIO

Watchlist Manager
Agios Pharmaceuticals Inc Logo
Agios Pharmaceuticals Inc
NASDAQ:AGIO
Watchlist
Price: 27.27 USD -0.69% Market Closed
Market Cap: 1.6B USD

Wall Street
Price Targets

AGIO Price Targets Summary
Agios Pharmaceuticals Inc

Wall Street analysts forecast AGIO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AGIO is 32.77 USD with a low forecast of 20.2 USD and a high forecast of 50.4 USD.

Lowest
Price Target
20.2 USD
26% Downside
Average
Price Target
32.77 USD
20% Upside
Highest
Price Target
50.4 USD
85% Upside
Agios Pharmaceuticals Inc Competitors:
Price Targets
87S
Roivant Sciences Ltd
15% Upside
LCTX
Lineage Cell Therapeutics Inc
133% Upside
CVAC
CureVac NV
5% Downside
HOWL
Werewolf Therapeutics Inc
472% Upside
301080
Acrobiosystems Co Ltd
39% Upside
EVAX
Evaxion Biotech A/S
103% Upside
688180
Shanghai Junshi Biosciences Co Ltd
28% Downside
AUPH
Aurinia Pharmaceuticals Inc
8% Upside

Revenue
Forecast

Revenue Estimate
Agios Pharmaceuticals Inc

For the last 12 years the compound annual growth rate for Agios Pharmaceuticals Inc's revenue is 3%. The projected CAGR for the next 4 years is 101%.

3%
Past Growth
101%
Estimated Growth
Estimates Accuracy
0%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Agios Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat

Net Income
Forecast

Net Income Estimate
Agios Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-13%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AGIO's stock price target?
Price Target
32.77 USD

According to Wall Street analysts, the average 1-year price target for AGIO is 32.77 USD with a low forecast of 20.2 USD and a high forecast of 50.4 USD.

What is Agios Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
101%

For the last 12 years the compound annual growth rate for Agios Pharmaceuticals Inc's revenue is 3%. The projected CAGR for the next 4 years is 101%.

Back to Top